Effects of retinoic acid (vitamin A) on tumor necrosis factor cytolytic action

Biochem Biophys Res Commun. 1995 Jan 5;206(1):223-9. doi: 10.1006/bbrc.1995.1031.

Abstract

Tumor necrosis factor (TNF) is a monokine produced primarily by macrophages. TNF has a number of activities including direct lysis of certain transformed cells and induction of antiviral activity. One of the protoypical transformed cell lines used for studying TNF cytolysis is murine L-929 cells. Because of the lysis, TNF has not been shown to have antiviral activity in these cells. Since retinoic acid (RA) induces a normal phenotype in the L-929 cells, we sought to determine if their conversion to a normal phenotype would 1) render them insensitive to the cytolytic effect and 2) allow for the development of an antiviral state. We present evidence that both the cis- and trans- forms of RA and to a lesser extent, the RA precursor beta-carotene, can inhibit recombinant human TNF cytolytic activity in mouse L-929 cells. However, blockage of the cytolytic activity does not allow development of an antiviral state.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • Carotenoids / pharmacology
  • Cell Survival / drug effects*
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Humans
  • Kinetics
  • L Cells
  • Mice
  • Recombinant Proteins / pharmacology
  • Tretinoin / pharmacology*
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / pharmacology*
  • Vesicular stomatitis Indiana virus / drug effects
  • beta Carotene

Substances

  • Antiviral Agents
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • beta Carotene
  • Carotenoids
  • Tretinoin